During the past decade, Island Neurological Associates conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 12 clinical trials were completed, i.e. on average, 120% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 4 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Island Neurological Associates" #1 sponsor was "Cady, Roger, M.D." with 3 trials, followed by "Eli Lilly and Company" with 3 trials sponsored, "Ipsen" with 3 trials sponsored, "Allergan" with 2 trials sponsored and "Genentech, Inc." with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Island Neurological Associates" #1 collaborator was "Allergan" with 1 trials as a collaborator, "Avanir Pharmaceuticals" with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator and "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Island Neurological Associates" are "Migraine" (3 trials), "Multiple Sclerosis" (3 trials), "Multiple Sclerosis, Relapsing-Remitting" (3 trials), "Cervical Dystonia" (2 trials) and "Chronic Migraine" (2 trials). Many other conditions were trialed in "Island Neurological Associates" in a lesser frequency.

Most popular intervention types in "Island Neurological Associates" are "Drug" (18 trials), "Biological" (4 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Botulinum toxin type A" (3 trials), "Ocrelizumab" (3 trials), "Galcanezumab" (2 trials) and "AGN-214868" (1 trials). Other intervention names were less common.

The vast majority of trials in "Island Neurological Associates" are 21 trials for "All" genders.

Currently, there are NaN active trials in "Island Neurological Associates". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Island Neurological Associates, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Island Neurological Associates, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 1 trials that are defined as “Not Applicable".